amifampridine has been researched along with Paraneoplastic Syndromes in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbusow, V | 1 |
| Voltz, RD | 1 |
| Strupp, M | 1 |
| Schulz, P | 1 |
1 other study available for amifampridine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Successful treatment of peripheral paraneoplastic neurological syndromes in small cell cancer.
Topics: 4-Aminopyridine; Aged; Amifampridine; Antineoplastic Agents; Carcinoma, Small Cell; Female; Humans; | 1998 |